odal Metastasis in Endometrial Cancer: Detection Methods and Clinical Significance of lymph node micrometastasis
Phase 2
Withdrawn
- Conditions
- endometrial canceruterine cancer10038594
- Registration Number
- NL-OMON34586
- Lead Sponsor
- Diakonessenhuis Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 245
Inclusion Criteria
The studie consists of two phases.
- Inclusion criteria for phase 1:
All women, suspicious for endometrial cancer, undergoing hysteroscopy and hysterectomy.
- Inclusion criteria for phase 2:
All women with high risk endometrial cancer, meaning that patients meet at least one of the following criteria:
> 50% myometrial invasion
differentiation grade 3
clearcell or serous papillary histology
carcinosarcoma
suspicious for extra-corporal spead
Exclusion Criteria
Patients with contraindications for open abdominal or laparoscopic surgery will be excluded: cervical or pelvic infection, severe cardio-pulmonal or other co-morbidity contra-indicating extensive surgery and anaesthesia.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method